Net Profit Margin ratio Analysis of Entrada Therapeutics Inc - Deep Dive


Latest FY NPM
Period Ending - Dec-23

-24.98


Very Poor NPM
Period Ending - Dec-22
-374.57

Very Poor NPM
Growth
93.33 %
Trailing Twelve Months NPM
Period Ending - Dec-23

14.42


Indecisive NPM
Most recent Quarter NPM
Period Ending - Mar-24

39.74


Excellent NPM
NPM Analysis of Entrada Therapeutics Inc
NPM Ratio of Entrada Therapeutics Inc with value of 39.74 indicates that a company is able to control its costs effectively and offer goods or services at a much higher price than its costs in latest Quarter ending on Mar-24.
NPM Ratio of TRDA rose handsomely by 93.33 % this year.
NPM Ratio with value of 0 was highest in Year Dec-21 in last Five Years.
NPM Ratio with value of -374.57 was lowest in Year Dec-22 in last Five Years.
Latest NPM Ratio with value of -24.98 is Greater than Average NPM of -79.91 in last five years.
NPM of Entrada Therapeutics Inc is negative because of negative Net Profit in FY ended on Dec-23.
Other NPM Related Info of TRDA that may interest you.
Entrada Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
TRDA15.4715.63 1.02 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit.   more ..
Net Profit Margin Formula
NPM Related Ratios
ReturnOnEquityEBITDAMargin
Tsr Profitability Index
Good Profitability
FY - Historical Net Profit Margin of Entrada Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
NPM-24.98-374.57000
Change93.33 %
FY Chart of Net Profit Margin of Entrada Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)